We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
+19.65%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$203M
AUM Growth
+$42.7M
Cap. Flow
+$11.4M
Cap. Flow %
5.61%
Top 10 Hldgs %
35.86%
Holding
61
New
2
Increased
15
Reduced
13
Closed

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$3.36M
2
XRAY icon
Dentsply Sirona
XRAY
+$3.23M
3
WAB icon
Wabtec
WAB
+$2.79M
4
MIDD icon
Middleby
MIDD
+$696K
5
DHR icon
Danaher
DHR
+$578K

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$321K
2
EMR icon
Emerson Electric
EMR
+$270K
3
IT icon
Gartner
IT
+$250K
4
ADSK icon
Autodesk
ADSK
+$55.9K
5
TECH icon
Bio-Techne
TECH
+$54K

Sector Composition

Rank Sector Weight
1 Healthcare 26.45%
2 Technology 26.19%
3 Industrials 22.35%
4 Materials 13%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKE icon
51
Oneok
OKE
$57.2B
$398K 0.2%
5,700
ABBV icon
52
AbbVie
ABBV
$443B
$390K 0.19%
4,850
JNJ icon
53
Johnson & Johnson
JNJ
$618B
$385K 0.19%
2,750
XOM icon
54
ExxonMobil
XOM
$644B
$370K 0.18%
4,579
ITW icon
55
Illinois Tool Works
ITW
$82.6B
$352K 0.17%
2,450
ABT icon
56
Abbott
ABT
$183B
$324K 0.16%
4,050
GE icon
57
GE Aerospace
GE
$374B
$281K 0.14%
5,662
-226
-4% -$10.6K
INTC icon
58
Intel
INTC
$455B
$277K 0.14%
5,160
D icon
59
Dominion Energy
D
$60.8B
$268K 0.13%
3,500
AMGN icon
60
Amgen
AMGN
$208B
$256K 0.13%
1,350
RDS.A
61
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$240K 0.12%
3,837

Similar funds

Stone Run Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Stone Run Capital held 61 positions worth $203M, up 27% from $161M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Stone Run Capital deployed $11.4M of net new capital in Q1 2019, opening 2 new positions and adding to 15 existing holdings. Its largest new stake was Linde: 20,250 shares worth $3.56M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Ansys, an estimated $321K trimmed.

  • Stone Run Capital's largest Q1 2019 buy was Linde: 20,250 shares worth $3.56M.
  • Stone Run Capital added most to Wabtec in Q1 2019, an estimated $2.79M increase.
  • Stone Run Capital's biggest Q1 2019 reduction was Ansys, cutting an estimated $321K.
  • Stone Run Capital's ten largest holdings make up 36% of its $203M portfolio in Q1 2019.
  • Stone Run Capital opened 2 new positions and closed 0 in Q1 2019.
  • Stone Run Capital's portfolio value rose 27% quarter-over-quarter to $203M.

Based on Stone Run Capital's 13F filing for Q1 2019, filed 14 May 2019.